Swiss industrial conglomerate Metall Zug reported a reduced net loss of 4.40 million Swiss francs in the first half of 2026, narrowing from a deeper shortfall in the prior-year period as net sales rose 5.5% to 95.60 million francs.
EBIT stood at negative 3.70 million francs, while the trading operating result reached break-even, reflecting improved operational performance. The medical devices unit turned profitable following structural changes and reduced R&D spending, with sales supported by higher unit volumes in the core slit lamp business.
Currency headwinds, particularly from a weaker U.S. dollar, weighed on reported sales figures and competitiveness during the period. Metall Zug did not provide financial guidance for the remainder of 2026, citing heightened volatility and limited visibility. The company reiterated confidence in the medium- and long-term prospects of its business units despite near-term uncertainty.
